Wijdicks E.F.M., Findlay, J
Bifidobacteria in antibiotic-associated dysbiosis: restoring balance in the gut microbiome
Peter examines the specific risks associated with nicotine use, including addiction, sleep disruption, cardiovascular concerns, and effects on mood and anxiety
For cagrilintide , Phase 2 data has shown meaningful weight loss when used as monotherapy, and the CagriSema combination (cagrilintide plus semaglutide) has entered Phase 3 trials under the REDEFINE programme by Novo Nordisk
Abstract Background The body-protective polypeptide BPC157 is a natural therapeutic agent that has demonstrated robust efficacy in promoting repair across multiple organ systems, indicating its significant clinical potential
If water isnt enough, add a stool softener like Colace